Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$66.81 - $80.83 $3.39 Million - $4.1 Million
-50,771 Closed
0 $0
Q1 2024

Aug 01, 2024

SELL
$61.03 - $69.57 $3.3 Million - $3.77 Million
-54,145 Reduced 51.61%
50,771 $3.44 Billion
Q4 2023

Aug 01, 2024

BUY
$61.89 - $69.28 $6.49 Million - $7.27 Million
104,916 New
104,916 $7.07 Billion

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Generate Investment Management LTD Portfolio

Follow Generate Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Generate Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Generate Investment Management LTD with notifications on news.